Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLSA stock hub

Tiziana Life Sciences Ltd has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLSAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

201.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TLSA

In the news

Latest news · TLSA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-924.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-580.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLSA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001723069
Company name	Tiziana Life Sciences Ltd
Country	United Kingdom
Country code	US
Cusip	88875G101
Employees	9
Employees Change	0%
Employees Change Percent	0
Enterprise value	$198.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2000-03-24
Isin	BMG889121031
Last refreshed	2026-05-10
Market cap	$201.6M
Market cap category	Micro-Cap
Price	$1.58
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	TLSA
Website	https://www.tizianalifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.14%
FCF yield	-6.38%
P/B ratio	3,877.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-18.4M
Net Income Growth Years	0%
Profit Per Employee	$-2M
ROA	-116
Roa5y	-62.22
ROCE	-7,388.8
ROE	-924.3
Roe5y	-282.3
ROIC	-580.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.64%
Cagr3y	26.52%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$11.5M
Cash	$4M
Current Assets	$12.7M
Current Liabilities	$7.4M
Debt	$456,000
Debt Equity	$8.77
Equity	$52,000
Liabilities	$11.4M
Long Term Assets	$-1.2M
Long Term Liabilities	$4M
Net Cash	$3.6M
Net Cash By Market Cap	$1.76
Net Cash Growth	14.41%
Net Debt Equity	$-68.35
Tangible Book Value	$52,000
Tangible Book Value Per Share	$0
WACC	6.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.76
Net Working Capital	$-6.4M
Quick ratio	0.72
Working Capital	$-2.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.64%
200-day SMA	1.65
3Y total return	102.56%
50-day SMA	1.31
50-day SMA vs 200-day SMA	50under200
All Time High	2.6
All Time High Change	-39.23%
All Time High Date	2025-08-01
All Time Low	0.41
All Time Low Change	285.37%
All Time Low Date	2024-04-15
ATR	0.11
Beta	0.4
Beta1y	-1.39
Beta2y	-0.66
Ch YTD	6.04
High	1.64
High52	2.6
High52 Date	2025-08-01
High52ch	-39.23%
Low	1.47
Low52	1.14
Low52 Date	2026-04-13
Low52ch	38.6%
Ma50ch	20.52%
Premarket Change Percent	1.99
Premarket Price	$1.54
Premarket Volume	220
Price vs 200-day SMA	-4.3%
RSI	72.69
RSI Monthly	53.78
RSI Weekly	54.72
Sharpe ratio	0.35x
Sortino ratio	0.64
Tr YTD	6.04
Tr1m	25.4%
Tr1w	17.91%
Tr3m	16.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.13
Operating Income	$-21.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	66,989,152%
Float Percent	52.49%
Net Borrowing	-196,000
Shares Insiders	47.51%
Shares Institutions	2.37%
Shares Out	127,624,007
Shares Qo Q	5.97%
Shares Yo Y	6.81%
Short Ratio	7.36
Short Shares	1.51

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.4M
Average Volume	163,111.75x
Bv Per Share	0
CAPEX	$-21,000
Ch1m	25.4
Ch1w	17.91
Ch1y	0.64
Ch3m	16.18
Ch3y	102.6
Ch6m	-9.71
Change	4.64%
Change From Open	4.64
Close	1.51
Days Gap	0
Depreciation Amortization	12,000
Dollar Volume	266,809.9
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-21.1M
EBITDA	$-21.1M
EPS	$-0.16
F Score	1
FCF	$-12.9M
FCF EV Yield	-6.5x
FCF Per Share	$-0.1
Financing CF	10,006,000
Fiscal Year End	December
Founded	2,013
Investing CF	3,043,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2025-05-06
Last Report Date	2025-06-30
Last Split Type	Never
Last10k Filing Date	2026-05-01
Ma150	1.55
Ma150ch	2%
Ma20	1.32
Ma20ch	20.06%
Net CF	286,000
Next Earnings Date	2026-05-22
Open	1.51
Optionable	Yes
Position In Range	63.86
Post Close	1.58
Postmarket Change Percent	-5.06
Postmarket Price	$1.5
Ppne	150,000
Pre Close	1.51
Price Date	2026-05-08
Ptbv Ratio	3,877.8
Relative Volume	1.04x
Share Based Comp	4,542,000
Tr6m	-9.71%
Volume	168,867

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLSA pay a dividend?

Capital-return profile for this ticker.

Performance

TLSA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLSA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.4%

Float: +52.5% of shares outstanding

Insider ownership

+47.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TLSA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.7

Above 70: short-term overbought

Price vs 200-day MA

-4.3%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLSA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TLSA stock rating?

Tiziana Life Sciences Ltd is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TLSA analysis?

The full report lives at /stocks/TLSA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TLSA?

The latest report frames TLSA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TLSA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.